Research reference · not medical advice

Peptide library

82 research peptides across 16 categories. Doses shown are the most commonly cited research ranges — always verify with primary sources.

Healing & Recovery

Skin & Cosmetic

Growth Hormone Axis

Tesamorelin

0.5h

Tesamorelin acetate (Egrifta)

GHRH analog. FDA-approved for HIV-associated lipodystrophy. Visceral fat reduction, IGF-1 elevation.

12 mg· Once daily, evening preferred

Sermorelin

0.2h

Sermorelin acetate (GRF 1-29)

29-amino-acid GHRH analog. Mild GH stimulation, sleep quality.

200500 mcg· Once daily, before bed

CJC-1295 (no DAC)

0.5h

Modified GRF 1-29 (Mod GRF)

Short-acting GHRH analog. Pulsatile GH release.

100200 mcg· 1-3x daily, often stacked with Ipamorelin

CJC-1295 (with DAC)

168h

CJC-1295 with Drug Affinity Complex

Long-acting GHRH. Sustained GH/IGF-1 elevation.

12 mg· 1-2x weekly

Ipamorelin

2h

Selective GHRP. Stimulates GH without affecting cortisol or prolactin.

200300 mcg· 1-3x daily

GHRP-2

0.5h

Growth Hormone Releasing Peptide 2

Stronger GH release than ipamorelin but raises prolactin/cortisol.

100300 mcg· 2-3x daily

GHRP-6

Growth Hormone Releasing Peptide 6

Strong GH release + appetite stimulation. Older generation.

100200 mcg· 2-3x daily

Hexarelin

Most potent GHRP. Strong GH spike but rapid receptor desensitization.

100200 mcg· 1-2x daily, cycle off after 4-6 weeks

MK-677 (Ibutamoren)

4h

Oral ghrelin receptor agonist. 24-hour GH/IGF-1 elevation. Not technically a peptide.

1025 mg· Once daily, oral

IGF-1 LR3

20h

Long R3 Insulin-like Growth Factor 1

Long-acting IGF-1 analog. Direct anabolic effects.

2080 mcg· Daily, post-workout common

Follistatin

Follistatin 344

Myostatin inhibitor. Promotes muscle growth by blocking activin and myostatin signaling.

100300 mcg· Daily for 10-30 days

GLP-1 / Metabolic

Weight Loss

Longevity

Immune

Nootropics

Sleep

Sexual Health

Pigmentation

Hormonal

Experimental

Bone Health

Bioregulators

Blends

BPC-157 + TB-500

BPC-157 + TB-500 ("Wolverine")

Flagship recovery stack researched for soft-tissue, tendon, ligament, and gut repair via angiogenesis and cell migration.

250500 mcg· Daily (loading) → 2-3x weekly

CJC-1295 (no DAC) + Ipamorelin

0.5h

CJC-1295 (no DAC) + Ipamorelin

Most popular GH-secretagogue pairing, studied for amplifying pulsatile GH release with minimal cortisol/prolactin impact.

100300 mcg· 1-3x daily (often pre-bed)

CJC-1295 (with DAC) + Ipamorelin

CJC-1295 (with DAC) + Ipamorelin

Longer-acting GHRH-analog variant paired with Ipamorelin, researched for sustained baseline GH elevation with fewer injections.

100300 mcg· 1-2x weekly (CJC) + Ipamorelin as scheduled

GHK-Cu + BPC-157

GHK-Cu + BPC-157

Copper peptide plus BPC-157, studied together for collagen synthesis, skin/tissue remodeling, and anti-inflammatory repair.

12 mg· Daily

GLOW (GHK-Cu + BPC-157 + TB-500)

GLOW — GHK-Cu + BPC-157 + TB-500

Three-peptide skin-and-recovery blend researched for tissue repair, vascular formation, and collagen/cellular signaling.

12 mg· Daily → maintenance

KLOW (GHK-Cu + BPC-157 + TB-500 + KPV)

KLOW — GHK-Cu + BPC-157 + TB-500 + KPV

GLOW base plus KPV, studied as a comprehensive tissue-repair blend adding antimicrobial/anti-inflammatory characterization.

12 mg· Daily → maintenance

Tesamorelin + Ipamorelin

Tesamorelin + Ipamorelin

GHRH analog plus ghrelin agonist, researched for visceral-fat reduction and body recomposition via the GH/IGF-1 axis.

12 mg· Nightly (often 5-on / 2-off)

Sermorelin + Ipamorelin

Sermorelin + Ipamorelin

GHRH analog plus ghrelin agonist studied for synergistic GH release, sleep, and body-recomposition endpoints.

200300 mcg· Pre-bed daily

HGH Frag 176-191 + CJC-1295 + Ipamorelin

HGH Fragment 176-191 + CJC-1295 (no DAC) + Ipamorelin

Cutting blend pairing a lipolytic GH fragment with GH secretagogues, studied for fat mobilization without hyperglycemia.

250500 mcg· Fasted / pre-cardio, daily

Retatrutide + Cagrilintide

Retatrutide + Cagrilintide ("Cagri-Reta")

Triple GLP-1/GIP/glucagon agonist paired with an amylin analog, researched as a four-pathway weight-management stack.

212 mg· Once weekly (slow titration)

Semaglutide + Cagrilintide (CagriSema)

Semaglutide + Cagrilintide ("CagriSema")

GLP-1 agonist plus amylin analog mirroring the investigational CagriSema combination for appetite and weight endpoints.

0.252.4 mg· Once weekly (titrated)

Tirzepatide + Cagrilintide

Tirzepatide + Cagrilintide

Dual GLP-1/GIP agonist plus amylin analog, researched as a three-receptor-pathway weight-management stack.

2.515 mg· Once weekly (titrated)

BPC-157 + KPV

BPC-157 + KPV

Gut-focused "guttide" pairing studied for intestinal-lining repair plus anti-inflammatory/immune modulation.

200500 mcg· 1-2x daily

NAD+ / MOTS-c / 5-Amino-1MQ

NAD+ + MOTS-c + 5-Amino-1MQ

Mitochondrial/metabolic blend studied for cellular energy, NAD+ preservation, and body-composition endpoints.

50100 mg· Daily → few x weekly
Peptide Catalog · PepStash